Histopathology

Histopathology: refers to the microscopic examination of tissue in order to study the manifestations of disease. In clinical medicine, histopathology refers to the examination of a biopsy or surgical specimen by a pathologist, after the specimen has been processed and histological sections have been placed onto glass slides.

Webinars

MAR 01, 2022 10:00 AM PST

MAR 01, 2022 10:00 AM PST

Impaired Dendritic Cell Homing in COVID-19

Date: March 01, 2022 Time: 10:00am (PST), 1:00pm (EST), 7:00pm (CEST) The high mortality of COVID-19 is mostly attributed to acute respiratory distress syndrome (ARDS), whose histopathologic...

Speaker: Lukas Borcherding , Ralf Huss, MD, PhD

Sponsored By: Visiopharm®

FEB 23, 2022 12:00 PM PST

C.E. CREDITS

FEB 23, 2022 12:00 PM PST

Panel Presentation: Digital Solutions to Alleviate NASH Clinical...

The prevalence of NASH in global populations continues to expand in conjunction with the ongoing obesity and diabetes epidemic. Over the next decade, the disease is projected to become the l...

Speaker: Paul McCracken, PhD , Debbie Marshall , Christina Gonzalez

Presented at: Drug Discovery & Development 2022

DEC 07, 2021 10:00 AM PST

C.E. CREDITS

DEC 07, 2021 10:00 AM PST

An overview of a novel RNAscope™ in situ hybridization technology,...

Date: December 07, 2021 Time: 10:00am (PST) The RNAscope™ technology allows high sensitivity and spatial resolution providing pivotal single-cell information to gain better insights in...

Speaker: Anushka Dikshit, PhD , Sebastien Monette

Sponsored By: ACD

NOV 13, 2020 6:00 PM PST

NOV 13, 2020 6:00 PM PST

Q&A Session (In the RoundTable Room)

Visit the RoundTable Room to participate in live Q&A with all the speakers!...

Speaker: Charalambos C. Solomides, MD , Sara Eglitis, MS, QIHC , Faruk Erdem Kombak, MD , Srabani Bhaumik, PhD , Nelson Alexander, PhD

Presented at: DISCOVERY Global User Symposium

NOV 13, 2020 2:00 PM PST

NOV 13, 2020 2:00 PM PST

Application of Ventana AmpHQ Technology at NovoVita

Incorporation of the TSA Technology available from Ventana’s AmpHQ kit allows for improved signal and reduced background in IHC staining at NovoVita Histopath Laboratory. This presenta...

Speaker: Sara Eglitis, MS, QIHC

Presented at: DISCOVERY Global User Symposium

NOV 12, 2020 11:00 AM PST

NOV 12, 2020 11:00 AM PST

Q&A Session (In the RoundTable Room)

Visit the RoundTable Room to participate in live Q&A with all the speakers!...

Speaker: Charalambos C. Solomides, MD , Sara Eglitis, MS, QIHC , Faruk Erdem Kombak, MD , Srabani Bhaumik, PhD , Nelson Alexander, PhD

Presented at: DISCOVERY Global User Symposium

NOV 12, 2020 7:00 AM PST

NOV 12, 2020 7:00 AM PST

Application of Ventana AmpHQ Technology at NovoVita

Incorporation of the TSA Technology available from Ventana’s AmpHQ kit allows for improved signal and reduced background in IHC staining at NovoVita Histopath Laboratory. This presenta...

Speaker: Sara Eglitis, MS, QIHC

Presented at: DISCOVERY Global User Symposium

NOV 12, 2020

C.E. CREDITS

NOV 12, 2020

Principles of Effective Method Development in Pathobiology Research

Immunohistochemistry (IHC) is used to determine spatial relationships where we can identify the localization of target proteins in specific regions and cells of a tissue. IHC has been the go...

Speaker: Vivian Barry, MS

Presented at: DISCOVERY Global User Symposium

OCT 08, 2020 10:30 AM PDT

C.E. CREDITS

OCT 08, 2020 10:30 AM PDT

Keynote Presentation: Principles of Effective Method Development...

Immunohistochemistry (IHC) is used to determine spatial relationships where we can identify the localization of target proteins in specific regions and cells of a tissue. IHC has been the go...

Speaker: Vivian Barry, MS

Presented at: Cancer Research & Oncology 2020Sponsored By: Roche Diagnostics

JUL 01, 2020 2:00 PM SGT

JUL 01, 2020 2:00 PM SGT

Operational strategies in molecular profiling of lung cancers

Lung cancer management has changed over the last few years with several actionable targets being recognised and mandated in the optimal management of these patients. The biomarker ordering p...

Speaker: Sudha Murthy, MD

Presented at: APJ Virtual Genetic Solutions Tour 2020

APR 21, 2020 1:30 PM PDT

APR 21, 2020 1:30 PM PDT

Spatially Resolved Molecular Investigation of Triple Negative...

Triple-negative breast cancer (TNBC) is an aggressive disease that accounts for 10-20% of all breast cancer cases diagnosed annually in the U.S.1. Despite its prevalence, TNBC remains resist...

Speaker: Dina Finan, PhD , Stephen Williams, PhD

Presented at: Genetics Virtual Week 2020

OCT 09, 2019 9:00 AM PDT

OCT 09, 2019 9:00 AM PDT

Start at the End: A Strategy for Developing and Delivering Advanced...

Although about one in every seven men in the developed world will be diagnosed with prostate cancer in their lifetime, the mortality rate remains low with a 99% five-year survival rate for lo...

Speaker: Stephen Pennington

Presented at: Cancer Research & Oncology 2019Sponsored By: Agilent

JUL 30, 2019 10:00 AM PDT

JUL 30, 2019 10:00 AM PDT

Validating antibodies for research applications in IHC

DATE: July 30, 2019TIME: 10:00am PT/ 1:00pm ET The importance of building a validation structure within your lab cannot be overstated. Once in place, the ability to identify high...

Speaker: Will Howat, PhD , Damian Cockfield

Sponsored By: Leica Biosystems

NOV 15, 2018 10:00 AM PST

NOV 15, 2018 10:00 AM PST

Multiplex fluorescence immunohistochemistry using the Ultivue...

DATE: November 15, 2018TIME: 10:00am PT, 1:00pm ET Multiplex fluorescence immunohistochemistry offers a window into the biology of human disease, enabling the ana...

Speaker: Traci DeGeer, BS, HT (ASCP) HTL, QIHC , Alexander Klimowicz

Sponsored By: Leica Biosystems

MAR 15, 2018 10:30 AM PDT

MAR 15, 2018 10:30 AM PDT

Overcoming Hurdles in the Study of Rare Diseases: Innovative Strategies...

The study of rare, neurological disorder and the development of effect treatments can pose many unique challenges. A paucity of scientists working on these disorders often limits forward prog...

Speaker: Jill Weimer, PhD

Presented at: Neuroscience 2018

OCT 12, 2017 12:00 PM PDT

OCT 12, 2017 12:00 PM PDT

Comprehensive genomic and transcriptomic analysis of acral melanoma:...

Acral lentiginous melanoma (ALM) is a rare sun-shielded melanoma subtype associated with worse survival than cutaneous melanoma (CM), a more common form of skin cancer linked to exposure to u...

Speaker: Winnie Liang, PhD

Presented at: Cancer Research & Oncology 2017

JUN 10, 2015 2:00 PM PDT

JUN 10, 2015 2:00 PM PDT

Personalized medicine

Matching the mutational profile of a patient's tumor with appropriate targeted agents is a goal of personalized medicine in oncology. The number of FDA-approved targeted therapies, as well as...

Speaker: Stephen Lyle, MD, PhD

Presented at: Cardinal Health labXchange

OCT 29, 2014 1:30 PM PDT

OCT 29, 2014 1:30 PM PDT

PDX Tumor Models for Oncology Research and Preclinical Prediction

Patient-derived xenograft (PDX) models can recapitulate patient tumor histopathology, mutational status, gene expression patterns, and drug response with remarkable fidelity. At The Jackson L...

Speaker: Walter Ausserer, PhD

Presented at: Cancer: Research, Discovery and Therapeutics

FEB 06, 2014 12:00 PM PST

C.E. CREDITS

FEB 06, 2014 12:00 PM PST

Molecular Diagnostic Tests To Advance Health Monitoring of Laboratory...

The zebrafish, Danio rerio, is an ideal model organism to address a broad array of biomedical questions, and is now widely employed to answer questions about aging, behavior, cancer, growth,...

Speaker: Marcus Crim, DVM

Presented at: Lab Animal Sciences 2014

FEB 05, 2014 1:00 PM PST

FEB 05, 2014 1:00 PM PST

Gross and Histopathologic Pathology of Rhesus Macaques

This seminar will cover spontaneous diseases of Rhesus Macaques utilizing a systemic approach. It will consist of gross and histopathologic images of common pathologic conditions highlighting...

Speaker: Olga Gonzalez, DVM

Presented at: Lab Animal Sciences 2014

MAR 01, 2022 10:00 AM PST

Impaired Dendritic Cell Homing in COVID-19

Date: March 01, 2022 Time: 10:00am (PST), 1:00pm (EST), 7:00pm (CEST) The high mortality of COVID-19 is mostly attributed to acute respiratory distress syndrome (ARDS), whose histopathologic...

FEB 23, 2022 12:00 PM PST

C.E. CREDITS

FEB 23, 2022 12:00 PM PST

Panel Presentation: Digital Solutions to Alleviate NASH Clinical...

The prevalence of NASH in global populations continues to expand in conjunction with the ongoing obesity and diabetes epidemic. Over the next decade, the disease is projected to become the l...

Speaker: Paul McCracken, PhD , Debbie Marshall , Christina Gonzalez

Presented at: Drug Discovery & Development 2022

DEC 07, 2021 10:00 AM PST

C.E. CREDITS

DEC 07, 2021 10:00 AM PST

An overview of a novel RNAscope™ in situ hybridization technology,...

Date: December 07, 2021 Time: 10:00am (PST) The RNAscope™ technology allows high sensitivity and spatial resolution providing pivotal single-cell information to gain better insights in...

NOV 13, 2020 6:00 PM PST

Q&A Session (In the RoundTable Room)

Visit the RoundTable Room to participate in live Q&A with all the speakers!...

Speaker: Charalambos C. Solomides, MD , Sara Eglitis, MS, QIHC , Faruk Erdem Kombak, MD , Srabani Bhaumik, PhD , Nelson Alexander, PhD

Presented at: DISCOVERY Global User Symposium

NOV 13, 2020 2:00 PM PST

Application of Ventana AmpHQ Technology at NovoVita

Incorporation of the TSA Technology available from Ventana’s AmpHQ kit allows for improved signal and reduced background in IHC staining at NovoVita Histopath Laboratory. This presenta...

NOV 12, 2020 11:00 AM PST

Q&A Session (In the RoundTable Room)

Visit the RoundTable Room to participate in live Q&A with all the speakers!...

Speaker: Charalambos C. Solomides, MD , Sara Eglitis, MS, QIHC , Faruk Erdem Kombak, MD , Srabani Bhaumik, PhD , Nelson Alexander, PhD

Presented at: DISCOVERY Global User Symposium

NOV 12, 2020 7:00 AM PST

Application of Ventana AmpHQ Technology at NovoVita

Incorporation of the TSA Technology available from Ventana’s AmpHQ kit allows for improved signal and reduced background in IHC staining at NovoVita Histopath Laboratory. This presenta...

NOV 12, 2020

C.E. CREDITS

NOV 12, 2020

Principles of Effective Method Development in Pathobiology Research

Immunohistochemistry (IHC) is used to determine spatial relationships where we can identify the localization of target proteins in specific regions and cells of a tissue. IHC has been the go...

OCT 08, 2020 10:30 AM PDT

C.E. CREDITS

OCT 08, 2020 10:30 AM PDT

Keynote Presentation: Principles of Effective Method Development...

Immunohistochemistry (IHC) is used to determine spatial relationships where we can identify the localization of target proteins in specific regions and cells of a tissue. IHC has been the go...

JUL 01, 2020 2:00 PM SGT

Operational strategies in molecular profiling of lung cancers

Lung cancer management has changed over the last few years with several actionable targets being recognised and mandated in the optimal management of these patients. The biomarker ordering p...

APR 21, 2020 1:30 PM PDT

Spatially Resolved Molecular Investigation of Triple Negative...

Triple-negative breast cancer (TNBC) is an aggressive disease that accounts for 10-20% of all breast cancer cases diagnosed annually in the U.S.1. Despite its prevalence, TNBC remains resist...

OCT 09, 2019 9:00 AM PDT

Start at the End: A Strategy for Developing and Delivering Advanced...

Although about one in every seven men in the developed world will be diagnosed with prostate cancer in their lifetime, the mortality rate remains low with a 99% five-year survival rate for lo...

JUL 30, 2019 10:00 AM PDT

Validating antibodies for research applications in IHC

DATE: July 30, 2019TIME: 10:00am PT/ 1:00pm ET The importance of building a validation structure within your lab cannot be overstated. Once in place, the ability to identify high...

NOV 15, 2018 10:00 AM PST

Multiplex fluorescence immunohistochemistry using the Ultivue...

DATE: November 15, 2018TIME: 10:00am PT, 1:00pm ET Multiplex fluorescence immunohistochemistry offers a window into the biology of human disease, enabling the ana...

MAR 15, 2018 10:30 AM PDT

Overcoming Hurdles in the Study of Rare Diseases: Innovative Strategies...

The study of rare, neurological disorder and the development of effect treatments can pose many unique challenges. A paucity of scientists working on these disorders often limits forward prog...

OCT 12, 2017 12:00 PM PDT

Comprehensive genomic and transcriptomic analysis of acral melanoma:...

Acral lentiginous melanoma (ALM) is a rare sun-shielded melanoma subtype associated with worse survival than cutaneous melanoma (CM), a more common form of skin cancer linked to exposure to u...

JUN 10, 2015 2:00 PM PDT

Personalized medicine

Matching the mutational profile of a patient's tumor with appropriate targeted agents is a goal of personalized medicine in oncology. The number of FDA-approved targeted therapies, as well as...

OCT 29, 2014 1:30 PM PDT

PDX Tumor Models for Oncology Research and Preclinical Prediction

Patient-derived xenograft (PDX) models can recapitulate patient tumor histopathology, mutational status, gene expression patterns, and drug response with remarkable fidelity. At The Jackson L...

FEB 06, 2014 12:00 PM PST

C.E. CREDITS

FEB 06, 2014 12:00 PM PST

Molecular Diagnostic Tests To Advance Health Monitoring of Laboratory...

The zebrafish, Danio rerio, is an ideal model organism to address a broad array of biomedical questions, and is now widely employed to answer questions about aging, behavior, cancer, growth,...

FEB 05, 2014 1:00 PM PST

Gross and Histopathologic Pathology of Rhesus Macaques

This seminar will cover spontaneous diseases of Rhesus Macaques utilizing a systemic approach. It will consist of gross and histopathologic images of common pathologic conditions highlighting...

Related Tags